Supplement Adverse Event Reports Grow, But FDA Says 'Serious' Intel Is Short
This article was originally published in The Rose Sheet
Executive Summary
Serious AERs submitted to FDA have plateaued since 2010, though reports the agency receives from consumers steadily increased. While FDA suspects supplement firms are not providing all serious AERs as required, stakeholders say the agency overestimates the number of serious AERs.
You may also be interested in...
Robust Internal AER Systems Follow Supplement Lifecycle – Nature's Bounty Expert
Robust dietary supplement adverse event compliance systems can support faster identification of problems and improve products, says Nature’s Bounty Product Vigilance Manager Christina Romano. During a recent CRN webinar, she said distributors, retailers and researchers should be part of the reporting system.
Causation Disclaimers Should Be In Adverse Event Reports Submitted To FDA
Dietary supplement firms should use a script for receiving AERs and establish review protocols to ensure serious events are reported to FDA, recommends attorney Claudia Lewis. She detailed best practices for supplement AERs at a recent American Conference Institute conference.
Bipartisan AER Bill Requires Reporting For All OTC Drugs, Supplements
Manufacturers of nonprescription drugs and dietary supplements will have to provide company contact information on product labels in order for consumers to report serious adverse events associated with the products under long-awaited legislation introduced June 21